EUCTR2013-004805-14-NL进行中（未招募）1 期
Vitamin K antagonist (VKA)versus New Oral Anticoagulants (NOACs) in patients with currently well controlled VKA therapy for non-valvular atrial fibrillation: a pilot study - GAIn
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 241
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Men or women aged >18 years who are currentlly treated with VKA for non-valvular AF, managed by participating Thrombosis Service
- •-A minimum duration of 6 months of VKA treatment prior to the screening visit.
- •- An ITTR> 60% over the 4 months of VKA treatment before selection by the Thromobosis Service
- •D4b. In het Nederlands
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 100
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 140
排除标准
- •-thrombo-embolic event or major bleeding ever while on VKA
- •-Indication for anticoagulation other then AF
- •-contra-indication to receive NOACs, i.e. reduced renal clearance defined as <30ml/min (Cockroft-Gault formula)
研究者
相似试验
尚未招募
不适用
Goede Antistolling In Noord Nederland: Vergelijking tussen vitamine K antagonisten (VKA) en nieuwe orale anticoagulantia in patienten met boezemfibrilleren die het nu goed doen op VKAantagonisten en Nieuwe Orale anticoagulantia in patienten die momenteel goed ingesteld zijn op een vitamine K antagonist.on-valvular atrial fibrillation Vitamin K antagonists New Oral AnticoagulantsNL-OMON28322niversity Medical Centre Groningen240
已完成
4 期
Vitamin K antagonist (VKA) therapy versus New Oral Anticoagulants (NOACs) therapy in patients with currently well controlled VKA therapy for non-valvular atrial fibrillation: a pilot studyatrial fibrillationcardiac arrhythmiaNL-OMON41389niversitair Medisch Centrum Groningen240
进行中（未招募）
1 期
The Direct Oral Anticoagulation versus Vitamin K Antagonist after Cardiac Surgery (DANCE) TrialPatients with atrial fibrillation requiring anticoagulation.MedDRA version: 20.0Level: PTClassification code: 10003658Term: Atrial fibrillation Class: 100000004849CTIS2023-504504-28-00Hamilton Health Sciences Corporation6,215
已完成
不适用
Prospective study of non-vitamin K antagonist oral anticoagulants (NOACs) management in Japanese patients with deep vein thrombosis and pulmonary embolism (DVT/PE)Venous thrombosisJPRN-UMIN000023747Department of Cardiology and Nephrology, Mie University Graduate School of Medicine1,000
进行中（未招募）
1 期
Administration of low risk oral anticoagulation agents to patients with pre-stage atrial fibrillation for stroke prophylaxisEUCTR2015-003997-33-PLKompetenznetz Vorhofflimmern e.V. (AFNET) [Atrial Fibrillation NETwork]2,538